Cancer & Disease Research
Illumina, Myriad Genetics provide U.S. access to HRD research test
Illumina and Myriad Genetics have expanded a strategic partnership aimed at broadening access to oncology homologous recombination deficiency (HRD) testing for oncology. Read More
Collaborative research helps long-COVID patients recover
In the NIH Directors Blog posted on Wednesday, Dr. Gary Gibbons of the National Heart, Lung, and Blood Institute writes about a National Institutes of Health (NIH) initiative, Researching COVID to Enhance Recovery (RECOVER). Read More
Stem cell-loaded plug improves outcomes in hard-to-treat Crohn’s disease patients
Most Crohn’s disease patients experienced complete clinical healing of perianal fistulas after treatment with a stem cell-loaded plug, according to data published in the journal Diseases of the Colon & Rectum. Read More
Active surveillance on the rise for low-risk prostate cancer
A large study indicates that active surveillance rates for managing low-risk prostate cancer are rising nationally, but are still suboptimal. Read More
Aiming targeted protein degradation at kinase unlocks potential way to treat Alzheimer’s
A targeted protein degrader could break apart a kinase implicated in Alzheimer’s disease to improve the cognitive abilities of patients with the neurodegenerative condition, according to a study published March 1 in ACS Central Science. Read More
Improved gut-on-chip devices spur research into how the microbiome affects human health
Gut-on-chip devices can now simulate microbial and human cellular biology to enable the analysis of the microbiome, according to a study published in APL Bioengineering. Read More
At SLAS 2023, companies showcase, launch advanced automation and screening technologies
At the Society for Laboratory Automation and Screening (SLAS) 2023 International Conference and Exhibition, being held in San Diego from February 25 to March 1, numerous firms have announced that they are showcasing emerging technologies for advanced life science applications. Read More
Rare cancer study identifies patients at high risk of metastasis
A large genomic study of a rare cancer called metastatic pheochromocytoma identified patients at high risk of metastasis, as well as those most likely to respond to immunotherapy. The results, published in Nature Communications on February 28, may allow closer following up of patients with poor prognoses, and facilitate more personalized treatments. Read More
Plugging immune cell leakage may improve melanoma treatment
NYU Langone Health researchers found in a study that the number of specialized immune cells available for fighting skin cancer doubled when a new treatment blocked their escape from melanoma tumors. The study, published February 27 in Nature Immunology, found that combining an immune cell exit blocker with another immunotherapy drug stopped melanoma tumor enlargement in more than half of the mice tested. Read More
Results of largest cell therapy trial shed light of effect on heart inflammation and strength
Physician-scientists at the Texas Heart Institute have published the results of a late-phase heart failure cell therapy clinical trial in the Journal of the American College of Cardiology. Read More
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter